Abstract
Fezolinetant for VMS: a balanced view on efficacy and safety needed - author's reply.
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Climacteric : the journal of the International Menopause Society
Paper Title
Journal
Date